OKEA And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – OKEA (OKEA.OL), RYANAIR HOLD. PLC (RYA.IR), ORKLA (ORK.OL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. OKEA (OKEA.OL)

66.5% sales growth and 32.98% return on equity

OKEA ASA, an oil and gas company, engages in the development and production of oil and gas in the Norwegian continental shelf. The company holds 44.56% interests in Draugen, 12% interests in Gjøa, 9.2385% interests in Ivar Aasen, 6% interests in Nova, and 15% interests in Yme assets. OKEA ASA was incorporated in 2015 and is headquartered in Trondheim, Norway.

Earnings Per Share

As for profitability, OKEA has a trailing twelve months EPS of kr6.27.

PE Ratio

OKEA has a trailing twelve months price to earnings ratio of 3.92. Meaning, the purchaser of the share is investing kr3.92 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.98%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 57.6% and positive 19.6% for the next.

Yearly Top and Bottom Value

OKEA’s stock is valued at kr24.56 at 21:20 EST, way under its 52-week high of kr41.36 and higher than its 52-week low of kr24.50.

Earnings Before Interest, Taxes, Depreciation, and Amortization

OKEA’s EBITDA is 4.

Volume

Today’s last reported volume for OKEA is 702142 which is 24.61% above its average volume of 563467.

More news about OKEA.

2. RYANAIR HOLD. PLC (RYA.IR)

38.7% sales growth and 28.95% return on equity

Ryanair Holdings plc, together with its subsidiaries, provides scheduled-passenger airline services in Ireland, the United Kingdom, Italy, Spain, and internationally. It is also involved in the provision of various ancillary services, such as non-flight scheduled and Internet-related services, as well as in-flight sale of beverages, food, duty-free, and merchandise; and markets car hire, travel insurance, and accommodation services through its website and mobile app. In addition, the company offers aircraft and passenger handling, ticketing, and maintenance and repair services; and markets car parking, fast-track, airport transfers, attractions, and activities on its website and mobile app, as well as sells gift vouchers. Ryanair Holdings plc was incorporated in 1996 and is headquartered in Swords, Ireland.

Earnings Per Share

As for profitability, RYANAIR HOLD. PLC has a trailing twelve months EPS of €1.95.

PE Ratio

RYANAIR HOLD. PLC has a trailing twelve months price to earnings ratio of 9.28. Meaning, the purchaser of the share is investing €9.28 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.95%.

More news about RYANAIR HOLD. PLC.

3. ORKLA (ORK.OL)

17.8% sales growth and 12.71% return on equity

Orkla ASA engages in branded consumer goods, and industrial and financial investment businesses. The company offers branded products, including frozen pizza, ketchup, soups, sauces, bread toppings, and ready-to-eat meals through grocery channels, as well as food service, convenience stores, and petrol stations. It also provides confectionery, biscuit, and snack products; and develops bran and crispbread products, as well as energy snack meals. In addition, the company offers personal care and cleaning products; dietary supplement, sport nutrition, and weight control products; wound care products and first aid equipment; painting tools; basic and wool garments for men, women, and children; and professional cleaning products. Further, it operates Gymgrossisten, Proteinfabrikken, Bodystore, and Fitnessmarket e-commerce portals for health and sports nutrition products; and restaurants. Additionally, the company supplies margarine and butter blends, bread and cake improvers and mixes, yeast, marzipan, and ice cream ingredients; produces and supplies hydro power to the Nordic power market; and develops and sells real estate properties. It offers its food products under the Grandiosa, TORO, Stabburet, Felix, Paulúns, NATURLI', Abba, Beauvais, Den Gamle Fabrik, Spilva, and Vitana brands; confectionery and snacks under the KiMs, Nidar, Stratos, Sætre, Göteborgs Kex, OLW, Panda, Laima, Selga, Taffel, Kalev, and Nói Síríus brands; health and sports nutrition under e Zalo, Jif, Bliw, Grumme, Blenda, Define, Möller's, Collett, Nutrilett, Maxim, Norgesplaster, and Salvequick brands; and food ingredients under the Odense, Mors Hjemmebakte, KronJäst, Bakkedal, and NATURLI brands. It has operations in Norway, Sweden, Denmark, Finland, Iceland, the Baltics, rest of Europe, and internationally. The company was founded in 1918 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, ORKLA has a trailing twelve months EPS of kr5.37.

PE Ratio

ORKLA has a trailing twelve months price to earnings ratio of 15.52. Meaning, the purchaser of the share is investing kr15.52 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.71%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 13.8%, now sitting on 66.13B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 1.5% and positive 16.7% for the next.

Moving Average

ORKLA’s value is higher than its 50-day moving average of kr79.34 and higher than its 200-day moving average of kr79.05.

More news about ORKLA.

4. BAKKAFROST (BAKKA.OL)

11.7% sales growth and 13.83% return on equity

P/F Bakkafrost, together with its subsidiaries, produces and sells salmon products under the Bakkafrost and Havsbrún brands in North America, Western Europe, Eastern Europe, Asia, and internationally. It operates through four segments: Farming FO; Farming SCT; Value Added Products; and Fishmeal, Oil and Fish Feed. The company is involved in the breeding and on-growing of salmon; harvesting, sale, and distribution of salmon; salmon farming, harvest, filleting, sales, and administration; and production of skinless and boneless portions of salmon. It also produces and sells fishmeal, fish oil, and fish feed. In addition, it engages in production of styrofoam boxes, and biogas and fertilizer; and operates trading of fishes, lumpfish farming business, and freight transportation of goods, as well as produce and sell canned fish products. P/F Bakkafrost was founded in 1968 and is headquartered in Glyvrar, Denmark.

Earnings Per Share

As for profitability, BAKKAFROST has a trailing twelve months EPS of kr11.04.

PE Ratio

BAKKAFROST has a trailing twelve months price to earnings ratio of 50.86. Meaning, the purchaser of the share is investing kr50.86 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.83%.

Moving Average

BAKKAFROST’s worth is under its 50-day moving average of kr623.15 and way below its 200-day moving average of kr629.09.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on May 2, 2023, the estimated forward annual dividend rate is 15.63 and the estimated forward annual dividend yield is 2.69%.

More news about BAKKAFROST.

5. VISTIN PHARMA (VISTN.OL)

6.6% sales growth and 16.03% return on equity

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.

PE Ratio

VISTIN PHARMA has a trailing twelve months price to earnings ratio of 24.3. Meaning, the purchaser of the share is investing kr24.3 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.

More news about VISTIN PHARMA.

6. ING GROEP N.V. (INGA.AS)

5.4% sales growth and 29.72% return on equity

ING Groep N.V., a financial institution, provides various banking products and services in the Netherlands, Belgium, Rest of Europe, North America, Latin America, Asia, and Australia. It operates in six segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, Wholesale Banking, and Corporate Line Banking. The company accepts various deposits, such as current and savings accounts. It also offers business lending products; consumer lending products, such as residential mortgage loans, term loans, and other consumer lending loans; and secured and unsecured lending services. in addition, the company provides debt capital market, working capital solutions, export finance, daily banking, treasury and risk, and corporate finance solutions; and specialized lending, debt and equity market solutions, payments and cash management, and trade and treasury services, as well as savings, investment, insurance, mortgage, and digital banking services; and SME loans. It serves individual customers, corporate clients, and financial institutions. ING Groep N.V. was founded in 1762 and is headquartered in Amsterdam, the Netherlands.

Earnings Per Share

As for profitability, ING GROEP N.V. has a trailing twelve months EPS of €1.62.

PE Ratio

ING GROEP N.V. has a trailing twelve months price to earnings ratio of 7.87. Meaning, the purchaser of the share is investing €7.87 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.72%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Aug 7, 2023, the estimated forward annual dividend rate is 0.7 and the estimated forward annual dividend yield is 5.43%.

Yearly Top and Bottom Value

ING GROEP N.V.’s stock is valued at €12.74 at 21:20 EST, under its 52-week high of €13.83 and way above its 52-week low of €9.59.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is 43.3% and a drop 2.3% for the next.

Volume

Today’s last reported volume for ING GROEP N.V. is 2357110 which is 78.68% below its average volume of 11060600.

More news about ING GROEP N.V..

Leave a Reply

Your email address will not be published. Required fields are marked *